MAKALELER


SCI, SSCI ve AHCI tarafından taranan dergilerde yayımlanmış veya kabul edilmiş makaleler

Ulusal
  • N.Gül Amuk , G.Kurt , M.Kartal Yandim , A.Adan and Y.Baran.
    (2018) A minimally invasive transfer method of mesenchymal stem cells to the intact periodontal ligament of rat teeth: A preliminary study.
    Turkish Journal Of Biology , Vol. 42, No. 5, 382-391,
Uluslararası
  • S.İsik , N.Uzuner , M.Karaman , O.Karaman , M.Kiray , I.Kozanoğlu , H.Bagriyanik , Z.Arikan Ayyildiz , M.Kartal Yandim and Y.Baran.
    (2017) Effects of intraperitoneal injection of allogeneic bone marrow-derived mesenchymal stem cells on bronchiolitis obliterans in mice model.
    Iranian Journal Of Allergy, Asthma And Immunology , Vol. 16, No. 3, 205-218,
  • Y.Kiraz , A.Adan , M.Kartal Yandim , Y.Baran.
    (2016) Major apoptotic mechanisms and genes involved in apoptosis.
    Tumor Biology , Vol. 37, No. 7, 8471-8486,
  • M.Kartal Yandim , A.Adan Gokbulut , Y.Baran.
    (2016) Molecular mechanisms of drug resistance and its reversal in cancer.
    Critical Reviews In Biotechnology , Vol. 36, No. 4, 716-726,
  • M.Kartal Yandim , C.Ceylan , E.Elmas , Y.Baran.
    (2016) A molecular and biophysical comparison of macromolecular changes in imatinib-sensitive and imatinib-resistant K562 cells exposed to ponatinib.
    Tumor Biology , Vol. 37, No. 2, 2365-2378,
  • N.G.Amuk , G.Kurt , Y.Baran , V.Seyrantepe , M.Kartal Yandim , A.Adan , S.Akyildiz Demir , Y.Kiraz , M.F.Sonmez.
    (2016) Effects of cell-mediated osteoprotegerin gene transfer and mesenchymal stem cell applications on orthodontically induced root resorption of rat teeth.
    European Journal Of Orthodontics ,
  • O.Tufekci , M.Kartal Yandim , H.Oren , G.Irken , Y.Baran.
    (2015) Targeting FoxM1 transcription factor in T-cell acute lymphoblastic leukemia cell line.
    Leukemia Research , Vol. 39, No. 3, 342-347,
  • B.Tezcanli Kaymaz , N.Selvi Gunel , M.Ceyhan , V.Bozok Çetintaş , B.Özel , M.Kartal Yandim , S.Kipcak , C.Aktan , A.Adan Gökbulut , Y.Baran and C.BK.
    (2015) Revealing genome-wide mRNA and microRNA expression patterns in leukemic cells highlighted "hsa-miR-2278" as a tumor suppressor for regain of chemotherapeutic imatinib response due to targeting STAT5A.
    Vol. 36, No. 10, 7915-7927,
  • M.Kartal Yandim , E.Apohan , Y.Baran.
    (2013) Therapeutic potential of targeting ceramide/glucosylceramide pathway in cancer.
    Cancer Chemotherapy And Pharmacology , Vol. 71, No. 1, 13-20,
  • A.Adan Gokbulut , M.Kartal Yandim , G.Iskender , Y.Baran.
    (2013) Novel agents targeting bioactive sphingolipids for the treatment of cancer.
    Current Medicinal Chemistry , Vol. 20, No. 1, 108-122,
  • I.Kozanoglu , M.Kartal Yandim , Z.Cincin , H.Ozdogu , B.Cakmakoglu , Y.Baran.
    (2013) New indication for therapeutic potential of an old well-known drug (propranolol) for multiple myeloma.
    Journal Of Cancer Research And Clinical Oncology , Vol. 139, No. 2, 327-335,
  • H.Kiper , B.Tezcanli Kaymaz , A.Adan Gokbulut , N.Selvi , C.Biray Avci , B.Kosova , G.Iskender , M.Kartal Yandim , C.Gunduz , F.Sahin , Y.Baran and G.Saydam.
    (2013) STAT pathway in the regulation of zoledronic acid-induced apoptosis in chronic myeloid leukemia cells.
    Biomedicine And Pharmacotherapy , Vol. 67, No. 6, 527-532,
  • G.Can , Z.Cakir , M.Kartal , U.Gunduz , Y.Baran.
    (2012) Apoptotic effects of resveratrol, a grape polyphenol, onimatinib-sensitive and resistant K562 chronic myeloid leukemia cells.
    Anticancer Research , Vol. 32, No. 7, 2373-2678,
  • C.Avci , S.Yilmaz , Z.Dogan , G.Saydam , Y.Dodurga , H.Ekiz , M.Kartal , F.Sahin , Y.Baran , C.Gunduz.
    (2011) Quercetin-induced apoptosis involves increased hTERT enzyme activity of leukemic cells.
    Hematology , Vol. 16, No. 5, 303-307,
  • M.Kartal , G.Saydam , F.Sahin , Y.Baran.
    (2011) Resveratrol triggers apoptosis through regulating ceramide metabolizing genes in human K562 chronic myeloid leukemia cells.
    Nutrition And Cancer , Vol. 63, No. 4, 637-644,
  • B.Kosova , B.Tezcanli , H.Ekiz , Z.Cakir , N.Selvi , A.Dalmizrak , M.Kartal , U.Gunduz , Y.Baran.
    (2010) Suppression of STAT5A increases chemotherapeutic sensitivity in imatinib-resistant and imatinib-sensitive K562 cells.
    Leukemia And Lymphoma , Vol. 51, No. 10, 1895-1901,

Diğer indexler tarafından taranan dergilerde yayımlanmış veya kabul edilmiş makaleler

Ulusal
  • O.Gokdemir , D.Ersil Soysal , H.Pak , M.Kartal Yandim , I.Semin .
    (2023) Evaluation of Polypharmacy in Individuals over 65 Years of Age in Balcova District of Izmir-Short Report.
    DAHUDER Medical Journal , Vol. 3, No. 2, 67-71,
  • M.Kartal Yandım , M.Bilgin.
    (2022) Shotgun Lipidomics Elucidates the Lipidome Alterations of the Mcl-1 Inhibitor S63845 in AML Cell Lines with a Focus on Sphingolipids.
    Experimed , Vol. 12, No. 3, 209-214,
Uluslararası
  • M.Kartal Yandim , I.Kozanoglu , H.Ozdogu , O.Piskin , M.A.Ozcan , G.Saydam , F.Sahin , F.Avcu , A.U.Ural , A.Unal , Y.Baran.
    (2020) Novel biomarkers for tyrosine kinase inhibitor resistance in chronic myeloid leukemia patients: Bioactive sphingolipids.
    Journal Of Hematology And Therapeutics , Vol. 2, No. 1, 1-7,